a) Terms/rights attached to equity shares:

The Company has only one class of shares referred to as equity shares having a par value of ' 5/- per share (Previous year ' 10/-per share). Each holder of equity shares is entitled to one vote per share.

In the event of liquidation of the Company, the holders of equity shares will be entitled to receive remaining assets of the Company, after distribution of all preferential amounts. The distribution will be in proportion to the number of equity shares held by the shareholders.

f) In last 5 years there was no Bonus Issue, buy back and /or issue of shares other for cash consideration.

g) Sub-division/split of equity shares

The Board of Directors of the Company at their meeting held on 30^th May 2025, had considered and approved the Stock Split/ Sub-division of every one equity share having face value of ' 10/ each, fully paid-up, into Two equity shares, having face value of ' 5/-each, fully paid-up and the same has been approved by the shareholders of the Company through Postal Ballot on 22^nd July 2025. Further the Company has fixed 12^th August 2025 as the “Record Date” for determining the entitlement of eligible Equity Shareholders for the purpose of sub-division/split of equity shares of the Company. Accordingly, the equity shares has been increased from 3,09,61,500 Equity shares to 6,19,23,000 Equity shares.

Nature of reserves

Reserve from Contingencies are created in earlier years to meet any contingencies in future and in the nature of free reserve.

General reserve amount transferred/ apportioned represents is in accordance with Indian Corporate law (The Companies Act, 1956) wherein a portion of profit is apportioned to general reserve, before a company can declare dividend.

Other comprehensive Income Reserve represent the balance in equity for items to be accounted in Other Comprehensive Income. oCi is classified into i) Items that will not be reclassified to profit & loss ii) Items that will be reclassified to profit & loss.

1 The Term Loans inter-se, are secured / to be secured by mortgage of all immovable properties of the Company both present and future and hypothecation of all movable properties of the Company (save and except book debts) including movable machinery, machinery spares, tools and accessories, both present and future subject to prior charges created and / or to be created in favour of the bankers of the Company on stocks, book debts and other specified movable properties for working capital requirements / Buyers Credit.

2 Vehicle Loan & others include loan of ' 491.39 lakh (Previous Year ' 520.68 lakh) secured by hypothecation of Motor Vehicles purchased there under which is repayable on different date.

3 Term Loan from bank of ' 2,475 lakh (Previous year ' 4,126 lakh), is repayable in 20 quarterly installments commenced from Nov 22.

4 Term Loan from bank of ' NIL lakh (Previous year ' 3,150), is repayable in 20 quarterly equal installments commenced from Dec 2024.

5 Term Loan from bank of ' Nil lakh (Previous year ' 1,249 lakh), is repayable in 13 equal quarterly installments commenced from Mar 23.

6 Term Loan from bank of ' 3,984 lakh (Previous year ' 5,990 lakh), is repayable in 20 equal quarterly installments commenced from June 23.

7 Term Loan from bank of ' Nil lakh (Previous year ' 500 lakh), is repayable in 48 equal monthly installments commencing from end of 13^th months from the date of disbursement.

8 Term Loan from bank of ' 4,125 lakh (Previous year ' 5,625 lakh), is repayable in 20 quarterly equal installments commenced from March 2024.

9 Term Loan from bank of ' 2,249 lakh (Previous year ' 3,373 lakh), is repayable in 24 quarterly equal installments commenced from Feb 2023.

10 Term Loan from bank of ' Nil lakh (Previous year ' 2,674 lakh), is repayable in 24 quarterly equal installments commenced from Dec 2022.

11 Term Loan from NBFC of ' Nil lakh (Previous year ' 4,275 lakh), is repayable in 24 quarterly equal installments commenced from Sept 2022.

12 Foreign Currency Term loan (converted from Term loan) from bank of USD Nil (Term loan - Previous Year - USD 4077420.86 (' 3,485 lakh)), is repayable in 28 quarterly installments commenced from Dec 2022.

13 Foreign Currency Term loan (converted from Term loan) from bank of USD 3285941.47 (Term loan - Previous Year - USD 5089488.72 (' 4,350 lakh)), is repayable in 28 equal quarterly instalments commenced from March 2021.

14 Term Loan from bank of ' 2,481 lakh (Previous year ' 3,065 lakh), is repayable in 24 quarterly equal installments commenced from Sep 2024.

15 Term Loan from bank of ' 4,500 lakh (Previous year ' 5,500 lakh), is repayable in 24 quarterly equal installments commenced from Nov 2024.

16 Term Loan from bank of ' 6,597 lakh (Previous year ' 7,500 lakh), is repayable in 24 quarterly installments commenced from June 2025.

17 Term Loan from bank of ' 3,828 lakh (Previous year ' 4,391 lakh), is repayable in 81 monthly installments commenced from July 2024.

18 Term Loan from bank of ' Nil lakh (Previous year ' 2,658 lakh), is repayable in 24 quarterly equal installments commenced from Sep 2024.

19 Term Loan from NBFC of ' Nil lakh (Previous year ' 8,846 lakh), is repayable in 26 quarterly equal installments commenced from Sept 2024.

20 Term Loan from NBFC of ' 3,654 lakh (Previous year ' 4,423 lakh), is repayable in 26 quarterly equal installments commenced from Sept 2024.

21 Term Loan from NBFC of ' 7,499 lakh (Previous year ' 9,167 lakh), is repayable in 72 Monthly equal installments commenced from Oct 2024.

22 Term Loan from NBFC of ' Nil lakh (Previous year ' 4,785 lakh), is repayable in 8 monthly equal installments commenced from July 2025.

23 Term Loan from Bank of ' 4,107 lakh (Previous year ' 3,294 lakh), is repayable in 28 quarterly equal installments commenced from Aug 2025.

24 Term Loan from NBFC of ' Nil lakh (Previous year ' 4,642 lakh), is repayable in 28 quarterly equal installments commenced from Dec 2024.

25 Term Loan from Bank of ' 3,831 lakh (Previous year ' 4,442 lakh), is repayable in 28 quarterly equal installments commenced from Oct 2024.

26 Term Loan from Bank of ' 4,166 lakh (Previous year ' 5,000 lakh), is repayable in 28 quarterly equal installments commenced from Oct 2025.

27 Term Loan from Bank of ' 6,620 lakh (Previous year ' 7,500 lakh), is repayable in 24 quarterly installments commenced from May 2025.

28 Term Loan from Bank of ' 3,925 lakh (Previous year ' 4,641 lakh), is repayable in 28 quarterly equal installments commenced from Nov 2024.

29 Term Loan from Bank of ' 5,893 lakh (Previous year ' 6,964 lakh), is repayable in 28 quarterly equal installments commenced from Nov 2024.

30 Term Loan from Bank of ' 3,500 lakh (Previous year ' 2,404 lakh), is repayable in 24 quarterly equal installments commenced from Aug 2025.

31 Term Loan from NBFC of ' 5,130 lakh (Previous year ' Nil), is repayable in 20 quarterly equal installments commenced from Oct 2025.

32 Term Loan from Bank of ' 4,666 lakh (Previous year ' Nil), is repayable in 24 quarterly equal installments commenced from Oct 2025.

33 Term Loan from Bank of ' 4,645 lakh (Previous year ' Nil), is repayable in 57 monthly equal installments commenced from Dec 2025.

34 Term Loan from NBFC of ' 2,208 lakh (Previous year ' Nil), is repayable in 60 monthly equal installments commenced from Sep 2025.

35 Term Loan from NBFC of ' 6,514 lakh (Previous year ' Nil), is repayable in 72 monthly equal installments commenced from Nov 2025.

36 Term Loan from Bank of ' 4,375 lakh (Previous year ' Nil), is repayable in 24 quarterly equal installments commenced from July 2025.

37 Term Loan from Bank of ' 7,306 lakh (Previous year ' Nil), is repayable in 21 quarterly equal installments commenced from Dec 2025.

38 Term Loan from Bank of ' 2,450 lakh (Previous year ' Nil), is repayable in 16 quarterly equal installments commenced from Dec

2025.

39 Term Loan from Bank of ' 4,097 lakh (Previous year ' Nil), is repayable in 24 quarterly equal installments commenced from Mar

2026.

40 Loan from Body Corporate of ' Nil lakh (Previous Year ' 3,000 lakh) is repayable only post confirmation from consortium banks and balance loan of ' 450 lakh (Previous Year ' 4,150 lakh) is payable after one year of balance sheet date.

(ii) Bills discounted with banks/others ' 267.97 Lakh (Previous Year: ' 646.70 Lakh).

B) Custom duty saved on import of raw material under Advance License pending fulfillment of export obligation amounting to ' 554.75 Lakh (Previous Year ' 484.21 Lakh). The Management is of the view that considering the past export performance and future prospects there is certainty that pending export obligation under advance licenses will be fulfilled before expiry of the validity of respective advance licenses, accordingly and also on “Going Concern Concept” basis there is no need to make any provision for custom duty saved.

39. Estimated amount of remaining to be executed on capital account and not provided for (net of advances contracts of ' 232.88 Lakh (Previous Year ' 353.94 Lakh) are ' 3,443.02 Lakh (Previous Year ' 6,374.74 Lakh).

40. In the earlier years, the State Government of Uttar Pradesh (UP) had imposed a levy of license fee on transfer of alcohol from the distillery to the chemical plant. The levy was challenged by the Company in the Hon’ble Supreme Court and on October 18, 2006 the matter was finally decided by The Hon’ble Supreme Court in favour of the Company. Accordingly, Company had filed an application for refund of amount paid ' 507.05 Lakh (Previous Year ' 507.05 Lakh) (shown as recoverable under the head “Other Current Assets”) with State Government of Uttarakhand, which is still pending for refund of the amount.

41. In the earlier year, Directorate of Revenue Intelligence (DRI) issued summons to the Company in connection with investigation in respect to import of Denatured Ethyl Alcohol by importer other than manufacturer of Excisable Goods and as per DRI, Company was not eligible for lower rate of BCD @ 2.5% under notification no. 50/2017 dated 30.06.2017. The Company has filed Writ Petition before Gujarat High Court that Company is eligible to avail benefit of concessional rate of 2.5% BCD on import of DEA and for quashing of investigations initiated by DRI. The Gujarat High Court has directed Customs Department not to pass final order till the pendency of Writ Petition Vide order dated 17.10.2024

Thereafter, a Show Cause notice no. 06//PC/2022-23 dated 03.08.2022 was issued alleging incorrect availment of Basic Customs Duty @2.5% instead of 5% during 01.07.2017 to 01.02.2021, as the imported DEA was not used for manufacture of Excisable Goods in terms of amended definition of Excisable Goods which now means to include only (a) Petroleum, (b) High Speed Diesel, (c) Motor Spirit, (d) Natural Gas, (e) Aviation Turbine Fuel, and (f) Tobacco.

Upon hearing, the Additional Commissioner has vide Order-in-Original No. 69/ADC/NOIDA-CUS/2023-24 dated 23.03.2024 has confirmed the duty demand of ' 4,093.05 lakh along with interest and has also imposed Redemption fine of ' 19,175.83 lakh and penalty of ' 4,100.00 lakh under sec 112(a)(i) of customs act and penalty of ' 4,100.00 lakh under Sec. 114AA of customs act and has also appropriated the amount of ' 750.00 lakh (Previous Year ' 750.00 Lakh) paid against the duty demand under protest is shown as recoverable from department, under the head “Other Current Assets”. The Company had filed an appeal before Commissioner of Customs (Appeals), GST Bhawan, NOIDA against the impugned Order-inOriginal. Vide Order-in-Appeal dated 27.02.2026, the Commissioner of Customs (Appeals) has partially allowed the Company’s appeal and upheld the impugned order in respect of the demand of ' 3,343.00 lakh towards short-paid duty, along with applicable interest and penalty. The penalties aggregating to ' 4100.00 lakh and the redemption fine of ' 19175.83 lakh have, however, been set aside. The Company is in the process of filing an appeal against the said Order-in-Appeal before the CESTAT, Allahabad.

42. The Board of Directors of the Company at its meeting held on 4^th February 2025, had approved the Composite Scheme of Arrangement (“Scheme”) involving amalgamation of Kashipur Holdings Limited (“KHL”) into the Company and Demerger of the Bio Pharma undertaking into a separate undertaking, namely, Ennature Bio Pharma Limited and Spirits & Biofuel Undertaking into a separate undertaking, namely, IGL Spirits Limited (“Demerger”) to be listed on both the stock exchanges. Further, the Scheme was subject to the requisite approvals and sanctions of the jurisdictional bench of National Company Law Tribunal and also subject to the approval of the shareholders and / or creditors of IGL, Central Government, or such other competent authority or intermediaries or agencies etc., as may be directed by the NCLT.

Further, post deliberations, to continue value creation for its stakeholders, the Board of Directors in its meeting held on 16^th May 2025 had decided to exclusively focus on Demerger as described in the above paragraph. The earlier proposal for the amalgamation of KHL into the Company will no longer form part of the Scheme being pursued. The proposed modification does not affect any stakeholders, including shareholders, creditors, or employees. There will be no adverse implication on the existing public shareholders of Transferee Company as they will continue to own the same percentage of shares in the Company. The appointed date for the Scheme of Arrangement is 1^st April 2026.

The parent company had filed applications with the Stock Exchanges for their No Objection/Observation Letters on the Scheme of Arrangement and received No Objection/Observation Letters from National Stock Exchange of India Limited and BSE Limited on 17^th and 19^th November 2025, respectively. Thereafter, the parent company had filed its First Motion Application before the Hon’ble NCLT, Allahabad Bench, Prayagraj (“NCLT”). The NCLT has allowed the application inter-alia, vide Order dated 15th January 2026 read with Order dated 16^th February 2026, has directed the parent company to convened separate meetings of Equity Shareholders and Unsecured Creditor on 24^th March, 2026 at which the Scheme was duly approved.

Thereafter, the parent company filed an application with the NCLT under the provisions of the Act for sanction of the Scheme. The application was admitted by the NCLT vide its Order dated 9^th April 2026, and the matter is scheduled for further hearing on 21^st May 2026.

43. (a) (i) In earlier year the company had given (included in current Loan) Inter Corporate Deposit (ICD) of ' 14,649.64

Lakh- -(Previous Year ' 14,649.64 Lakh) to its subsidiary IGL Finance Ltd. (IGLFL) (A 100% subsidiary). iGlFL in earlier year had invested funds for short term in commodity financing contracts offered by National Spot Exchange Ltd. (NSEL). NSEL had defaulted in settling the contracts on due dates, for which IGLFL has initiated legal and other action and in turn IGLFL did not pay back due amount to the company. Accordingly considering the prudence no interest on above ICD has been accrued for the period from 01-09-2013 onwards.

(ii) In respect of the above, the Company has made a loss allowance of ' 11,719.71 Lakh based on expected credit loss Policy and other estimation made by the management and for balance ' 2,041.93 Lakh (and also fully provided for against equity investment of ' 125.00 Lakh), the management and IGLFL is confident for recovery of dues from NSEL over a period of time and hence shown as good (considering the measure which have so far been taken for and pending before the Govt. and other authorities and current scenario/present state of affairs.). However, during the earlier year, the Company has written off ICD of ' 11,719.71 Lakh and adjusted the same against the provision, which was created in earlier year. Hence there was no impact on profitability of the company.

(b) In earlier years, Company has Investment of ' 27.41 Lakh & ' 127.00 lakh in equity share capital in subsidiaries namely IGL CHEM International PTE Ltd, Singapore & IGL CHEM International UsA LLC respectively, whose net worth has been fully eroded. In the Financial Year 2023-24, the company created the provision for diminution in value of investment for the same.

45. Financial risk management objectives and Policies

The Company's activities are exposed to a variety of financial risks from its operations. The key financial risks include market risk (including foreign currency risk, interest rate risk and commodity risk etc.), credit risk and liquidity risk. The company's overall risk management policy seeks to minimize potential adverse effects on company's financial performance.

(i) Market Risk: Market risk is the risk that the fair value of future cash flow of a financial instruments will fluctuate because of change in market prices. Market risk comprises mainly three types of risk: interest rate, currency risk and other price risk such as commodity price risk.

(a) Foreign Currency Risk: Foreign Currency risk is the risk that the fair value or future cash flows of an exposure will fluctuate because of changes in foreign exchange rates. The company has obtained foreign currency borrowing and has foreign currency trade payable and receivable and is therefore, exposed to foreign currency risk.

After taking cognizance of the natural hedge, the company takes appropriate hedge to mitigate its risk resulting from fluctuation in foreign currency exchange rate(s).

Foreign Currency sensitivity: The following table demonstrate the sensitivity to a reasonable possible change in Foreign Currency with all other variable held constant. The impact on company's profit/(loss) before tax is due to change in the foreign exchange rate for:

(b) Interest rate risk:- Interest rate risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market interest rates. Any change in the interest rates environment may impact future rates of borrowings. The company mitigates this risk by regularly assessing the market scenario, finding appropriate financial instruments, interest rate negotiation with the lenders for ensuring the cost effective method of financing.

Interest Rate Sensitivity: The following table demonstrates the sensitivity to a reasonable possible change in interest rate on financial assets affected. With all other variable held constant, the company's profit before tax is affected through the impact on finance cost with respect to our borrowings, as follows:

(c) Commodity Price risk: The Company is affected by the price volatility of certain commodities. Its operating activities require the purchase of raw material therefore, requires a continuous supply of certain raw materials. To mitigate the commodity price risk, the Company has an approved supplier base to get competitive prices for the commodities and to assess the market to manage the cost without any comprise on quality.

(ii) Credit Risk:

Credit risk refers to risk that a counter party will default on its contractual obligations resulting in financial loss to the Company. Credit risk arises primarily from financial assets such as trade receivables, Inter Corporate deposit, derivative financial instruments, other balances with banks, loans and other receivables. The Company's exposure to credit risk is disclosed in Note 6, 7, 8, 11, 14 & 15.

Credit risk arising from investment in derivative financial instruments and other balances with banks is limited and there is no collateral held against these because the counter parties are banks and recognised financial institutions with high credit ratings.

The Company applies expected credit losses (ECL) model for measurement and recognition of loss allowance on the following:

i. Trade receivables

ii. Financial assets measured at amortized cost (other than trade receivables)

In case of trade receivables, the Company follows a simplified approach wherein an amount equal to lifetime ECL is measured and recognized as loss allowance.

ECL impairment loss allowance (or reversal) recognized during the period is recognized as income/ expense in the Statement of Profit and Loss under the head 'Other expenses'. The balance sheet presentation for financial instruments is described below:

Financial assets measured as at amortised cost: ECL is presented as an allowance, i.e., as an integral part of the measurement of those assets in the balance sheet. The allowance reduces the net carrying amount. Until the asset meets write-off criteria, the company does not reduce impairment allowance from the gross carrying amount.

(iii) Liquidity Risk: Liquidity risk is the risk, where the company will encounter difficulty in meeting the obligations associated with its financial liabilities that are settled by delivering cash or another financial asset. The company's approach to ensure, as far as possible, that it will have sufficient liquidity to meet its liabilities when due.

46. Capital risk management

The Company's policy is to maintain an adequate capital base so as to maintain creditor and market confidence and to sustain future development. Capital includes issued capital, share premium and all other equity reserves attributable to equity holders. The primary objective of the Company's capital management is to maintain an optimal structure so as to maximize the shareholder's value. In order to strengthen the capital base, the company may use appropriate means to enhance or reduce capital, as the case may be.

The Company is not subject to any external imposed capital requirement. The company monitors capital using a gearing ratio, which is net debt divided by total capital plus net debt. Net Debt is calculated as borrowings less cash and cash equivalents.

interest payable amounts for delayed payments to such vendors at the Balance Sheet date. There are no delays in payment made to such suppliers during the year or for any earlier years and accordingly there is no interest paid or outstanding interest in this regard in respect of payment made during the year or on balance brought forward from previous year.

49. Other Particulars:

(a) Details of Loan given during the year covered under Section 186(4) of the Companies Act, 2013 :

Nil

(B) The Company has derivative instruments for hedging possible losses and exchange fluctuation losses. During the year company has incurred net off gain of ' 107.53 Lakh (previous year ' 417.99 Lakh -loss) out of which gain of ' 93.24 Lakh (previous year loss of ' 448.53 Lakh) relating to provision for mark to market gain/loss on account of outstanding financial transactions as on 31^st March 2026.

52. Fair valuation techniques

The Company maintains policies and procedures to value financial assets or financial liabilities using the best and most relevant data available. The fair values of the financial assets and liabilities are included at the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

The following methods and assumptions were used to estimate the fair values:

1) Fair value of cash and deposits, trade receivables, trade payables, and other current financial assets and liabilities approximate their carrying amounts largely due to the short-term maturities of these instruments.

2) Fair value of borrowings from banks and other non-current financial liabilities, are estimated by discounting future cash flows using rates currently available for debt on similar terms and remaining maturities.

3) Other non-current receivables are evaluated by the Company, based on parameters such as interest rates, individual creditworthiness of the counterparty etc. Based on this evaluation, allowances are taken to account for the expected losses of these receivables.

4) The fair values of derivatives are calculated using the RBI reference rate as on the reporting date as well as other variable parameters.

Fair Value hierarchy

All financial assets and liabilities for which fair value is measured in the financial statements are categorised within the fair

value hierarchy, described as follows: -

Level 1 - Quoted prices in active markets.

Level 2 - Inputs other than quoted prices included within Level 1 that are observable, either directly or indirectly.

Level 3 - Inputs that are not based on observable market data.

The following table presents the fair value measurement hierarchy of financial assets and liabilities, which have been

measured subsequent to initial recognition at fair value as at 31^st March, 2026 and 31^st March 2025:

57. Segment Information:

Disclosures as required by Indian Accounting Standard (Ind AS) 108 Operating Segments Identifications of Segments:

Segments have been identified in line with Indian Accounting Standard on 'Operating Segments' (Ind AS -108), taking into account the organizational structure as well as the differential risk and returns of this segment and as per the quantitative criteria specified under IND AS. The Company has identified the following segments:

Operating Segments:

Bio-based Specialities and Performance Chemicals Segment comprises Glycols, Specialty Chemicals, Natural Gum & other related goods etc. Potable Spirits Segment comprises manufacture and sale of Ethyl Alcohol (Potable). Ennature Biopharma comprises manufacture and sale of Nutraceutical Products. Bio-fuel comprises Ethanol, DDGS & DWGS.

62. During the year, effective 21^st November 2025, the Government of India has consolidated multiple existing labour legislations into a unified framework comprising of four Labour Codes - the Code on Wages, 2019, the Industrial Relations Code, 2020, the Code on Social Security, 2020, and the Occupational Safety, Health and Working Conditions Code, 2020, collectively referred to as the 'New Labour Codes'. The enactment of these codes has resulted in changes to the computation of certain employee benefits. The Company has assessed the impact of these changes in accordance with Ind AS 19 -Employee Benefits and the guidance Issued by the Institute of Chartered Accountants of India (ICAI). The resulting additional employee benefit expense of ' 82.89 lakh, being non-recurring, has been presented under "Exceptional Items". The Company continues to monitor further notifications and rules under the new Labour Codes and will account for any additional Impact as required

63. The Board of Directors of the Company at their meeting held on 16^th October, 2025 had considered and approved the Raising funds through Issuance of up to 51,03,765 Equity Shares of Face Value of ' 5/- each, at a price of ' 915/- per Equity Share, (including a premium of ' 910/- per equity share), determined in accordance with the provisions of Chapter

V of SEBI (Issue of capital and Disclosure Requirements) Regulations, 2018 ("SEBI ICDR Regulations"), for cash, for an aggregate amount of up to ' 4,66,99,44,975/- on preferential basis and the same has been approved by the shareholders of the company at their Extraordinary General Meeting held on 12^th November 2025. The Preferential Allotment Committee of the Board completed the allotment of the aforesaid equity shares to the respective allottees on 24^th November 2025 and the Company's paid-up share capital was accordingly increased to ' 33,51,33,825/-. The listing and trading approvals from the Stock Exchanges for above acquired equity shares were obtained on 5^th January, 2026 effective from 6^th January, 2026.

64. Other Statutory Information:

a. The Company does not have any Benami property, where any proceeding has been initiated or pending against the Company for holding any Benami property.

b. There are no transactions and / or balance outstanding with companies struck off under section 248 of the Companies Act, 2013.

c. The Company does not have any charges or satisfaction which is yet to be registered with ROC beyond the statutory period.

d. The Company has not advanced or loaned or invested funds to any other person(s) or entity(ies), including foreign entities (Intermediaries) with the understanding that the Intermediary shall:

i) directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Company (Ultimate Beneficiaries) or

ii) provided any guarantee, security or the like to or on behalf of the Ultimate Beneficiaries.

e. The Company has not received any fund from any person(s) or entity(ies), including foreign entities (Funding Party) with the understanding (whether recorded in writing or otherwise) that the Group shall:

i) directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Funding Party (Ultimate Beneficiaries) or

ii) provided any guarantee, security or the like to or on behalf of the Ultimate Beneficiaries.

f. The Company does not any transactions which are not recorded in the books of accounts that have been surrendered

or disclosed as income during the year in the tax assessments under the Income Tax Act, 1961 (such as, search or survey or any other relevant provisions of the Income Tax Act, 1961).

g. The company does not have any investments through more than two layers of investment companies as per section 2(87) (d) and section 186 of Companies Act, 2013.

h. The Company has not traded or invested in Crypto currency or Virtual Currency during the financial year.

i. The Title deeds of the immovable properties (other than properties where the Company is the lessee and the lease

agreements are duly executed in favour of the lessee) are held in the name of the Company

j. The Company has sanctioned facilities from banks on the basis of security of current assets. The periodic returns filed by the Company with such banks are in agreement with the books of accounts of the Company

k. The Company has adhered to debt repayment and interest service obligations on time. Wilful defaulter related disclosures required as per Additional Regulatory Information of Schedule III (revised) to the Companies Act, is not applicable.

l. Term loans availed by the Company were, applied by the Company during the year for the purposes for which the loans were obtained.

65. The figures of the previous period/year have been restated/regrouped wherever necessary, to make them comparable.